These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 3891937)

  • 1. The patho-epidemiology of benign proliferative epithelial disorders of the female breast.
    Cook MG; Rohan TE
    J Pathol; 1985 May; 146(1):1-15. PubMed ID: 3891937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menstrual and reproductive history, postmenopausal hormone use, and risk of benign proliferative epithelial disorders of the breast: a cohort study.
    Cui Y; Page DL; Lane DS; Rohan TE
    Breast Cancer Res Treat; 2009 Mar; 114(1):113-20. PubMed ID: 18360772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond fibrocystic disease. The evolving concept of pre-malignant breast disease.
    Shirley SE
    West Indian Med J; 1999 Dec; 48(4):173-8. PubMed ID: 10639833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cigarette smoking and risk of benign proliferative epithelial disorders of the breast in the Women's Health Initiative.
    Cui Y; Page DL; Chlebowski RT; Hsia J; Allan Hubbell F; Johnson KC; Rohan TE
    Cancer Causes Control; 2007 May; 18(4):431-8. PubMed ID: 17323143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.
    Marshall LM; Hunter DJ; Connolly JL; Schnitt SJ; Byrne C; London SJ; Colditz GA
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):297-301. PubMed ID: 9149887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case-control study of diet and benign proliferative epithelial disorders of the breast.
    Rohan TE; Cook MG; Potter JD; McMichael AJ
    Cancer Res; 1990 Jun; 50(11):3176-81. PubMed ID: 2334913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomorphology of fibrocystic change, high-risk proliferative breast disease, and premalignant breast lesions.
    Masood S
    Clin Lab Med; 2005 Dec; 25(4):713-31, vi. PubMed ID: 16308088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.
    Worsham MJ; Raju U; Lu M; Kapke A; Cheng J; Wolman SR
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5474-9. PubMed ID: 17875777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cohort study of oral contraceptive use and risk of benign breast disease.
    Rohan TE; Miller AB
    Int J Cancer; 1999 Jul; 82(2):191-6. PubMed ID: 10389751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial dysplasia in nipple aspirates of breast fluid: association with family history and other breast cancer risk factors.
    Petrakis NL; Ernster VL; King EB; Sacks ST
    J Natl Cancer Inst; 1982 Jan; 68(1):9-13. PubMed ID: 6948129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for premalignant lesions in the human breast.
    Sloane JP
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():17-21. PubMed ID: 8298446
    [No Abstract]   [Full Text] [Related]  

  • 12. Frequency of benign and preinvasive breast diseases.
    Altaf FJ; Abdullah LS; Jamal AA
    Saudi Med J; 2004 Apr; 25(4):493-7. PubMed ID: 15083223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of risk factors in counseling patients.
    Love SM
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):599-610. PubMed ID: 2691491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological pattern of benign breast disease as a risk factor for invasive breast cancer.
    Bianchi S; del Turco MR; Simoncini R; Distante V; Russo A; Palli D
    Cancer Detect Prev; 1992; 16(1):17-9. PubMed ID: 1551133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol consumption and risk of benign proliferative epithelial disorders of the breast in women.
    Rohan TE; Cook MG
    Int J Cancer; 1989 Apr; 43(4):631-6. PubMed ID: 2703271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of proliferative breast lesions around breast cancers].
    Moriya T; Manabe T; Sakurai T; Sakamoto K
    Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():42-5. PubMed ID: 7747991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial.
    Rohan TE; Negassa A; Chlebowski RT; Habel L; McTiernan A; Ginsberg M; Wassertheil-Smoller S; Page DL
    J Natl Cancer Inst; 2008 Apr; 100(8):563-71. PubMed ID: 18398105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between component parts of fibrocystic disease complex and breast cancer.
    Page DL; Vander Zwaag R; Rogers LW; Williams LT; Walker WE; Hartmann WH
    J Natl Cancer Inst; 1978 Oct; 61(4):1055-63. PubMed ID: 279711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preneoplasia of the breast.
    Böcker W
    Verh Dtsch Ges Pathol; 1997; 81():502-13. PubMed ID: 9474891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillary apocrine change of the breast: associations with atypical hyperplasia and risk of breast cancer.
    Page DL; Dupont WD; Jensen RA
    Cancer Epidemiol Biomarkers Prev; 1996 Jan; 5(1):29-32. PubMed ID: 8770463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.